Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Applying to Kaiser Permanente-Capitol Hill Medical Center · Washington D.C., District of Columbia
Answer a few short questions to share with the research team.